The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the novalgin that was given to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.From the device perspective, there was no known device malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event no product was returned therefore, a device service history review was performed.The instrument has been located at the customer's site since (b)(6) 2012.As part of the review, it was determined that the instrument's last service was on (b)(6) 2016 during this service the system checkout procedure was successfully completed indicating that the instrument had passed all tests, met all specifications, and was operational.Trends were reviewed for complaint categories, chills and fever.No trends were detected for these complaint categories.The assessment is based on information available at the time of the investigation.No product was returned for investigation; therefore, it could not be determined if the product met specification based solely on the information provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: chills and fever.
|
The customer reported that a patient started shivering five minutes after a successfully completed treatment.The customer stated that the patient's temperature was 38,4 º c at this time, while the patient's temperature before treatment was: 36,6º c.The customer reported that the patient was administered a 1gr.Novalgin in 250ml saline infusion.The customer stated that the patient was in stable condition.No product was returned for investigation.
|